End-stage Renal Disease
Conditions
Brief summary
A randomized clinical trial for patients with end stage renal disease in which a family consultation condition is compared against a treatment as usual control condition on the hospital readmissions after 1 month as the primary outcome variable.
Detailed description
Patients hospitalized at Henry For Hospital who have end stage renal disease will complete baseline questionnaires and be randomized into the experimental or control condition. Patients randomized into the experimental condition will have a single family consultation session before the patient is discharged. A trained, master's level therapist will conduct the family consultation, which will use education, motivational interviewing, and other techniques to help the family engage and support the patient's health needs. Patients in both the experimental and control conditions will complete follow up questionnaires 1 month after discharge. Investigators will conduct chart reviews of outcome data, including readmissions, at 1, 3, and 6 months post-discharge.
Interventions
BEHAVIORALFamily Consultation
This intervention is based on psychoeducation, social support mobilization, and motivational interviewing techniques.
Sponsors
Henry Ford Health System
Mark A. Lumley
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Hospitalized in inpatient Nephrology Unit at Henry Ford Hospital * Has end-stage renal disease * Willing and able to contact support person / family member about participating in the study
Exclusion criteria
* Persistent Delirium * Non-English speaking
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Early Hospital Readmissions - 1 Month | 1 Month | Were patients readmitted to the hospital within 1 month of their initial discharge? |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Medication Adherence | Baseline and 1-month follow-up | Adherence to medication regimen. Items modified from Immunosuppressant Therapy Adherence Scale. |
| Change in Depression | Baseline and 1-month follow-up | Assessed using Patient Health Questionnaire 8 |
| Change in Instrumental Social Support | Baseline and 1-month follow-up | Amount of involvement of support people in terms of disease management. Items modified from the Diabetes Social Support Questionnaire-Family. |
| Change in Biological Measures of Health | Baseline, 1, and 3 months | Based on chart review, investigators will assess BUN, creatinine, substance use (tox screen), phosphorous, comorbidities, mortality |
| Hospital Readmissions - 3 Months | 3 Months | Were patients readmitted to the hospital within 3 months of their initial discharge? |
| Change in Anxiety | Baseline and 1-month follow-up | Assessed using Generalized Anxiety Disorder Questionnaire-7 |
Countries
United States
Outcome results
None listed